Three pharmaceutical companies have linked hands with the voluntary and public sectors under a unique joint working partnership that aims to improve the management of patients with epilepsy in Dumfries and Galloway, Scotland. Drugmakers UCB, Eisai and GlaxoSmithKline have entered the pact alongside NHS Dumfries and Galloway and Epilepsy Scotland in the hope that working more closely together will significantly benefit over 1,500 patients with the condition living in the area. Under the plans, a specialist nurse from Epilepsy Scotland will provide training to a wide range of healthcare professionals in order to enhance staff expertise, developing new pathways and protocols as well as providing advice and support for further staff training.
